Nurix Therapeutics (NRIX) News Today $12.69 +0.25 (+2.01%) Closing price 04:00 PM EasternExtended Trading$12.75 +0.06 (+0.48%) As of 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRIX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Nurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $34.00 at HC WainwrightJuly 14 at 10:41 AM | marketbeat.comLeerink Partnrs Analysts Lift Earnings Estimates for NRIXJuly 14 at 2:38 AM | marketbeat.comNurix Therapeutics Could Disrupt BTK Therapy And Reward InvestorsJuly 13 at 9:05 AM | seekingalpha.comNurix Therapeutics (NASDAQ:NRIX) Given New $26.00 Price Target at UBS GroupJuly 13 at 3:15 AM | americanbankingnews.comStephens Reaffirms "Overweight" Rating for Nurix Therapeutics (NASDAQ:NRIX)July 13 at 2:35 AM | americanbankingnews.comNurix Therapeutics (NASDAQ:NRIX) Given New $30.00 Price Target at OppenheimerJuly 12 at 3:11 AM | americanbankingnews.comNurix Therapeutics beats quarterly expectations on strong collaboration ...July 11 at 1:36 PM | investing.comUBS Group Cuts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $26.00July 10, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Shares Gap Up After Earnings BeatJuly 10, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $30.00 at OppenheimerJuly 10, 2025 | marketbeat.comNurix Therapeutics' (NRIX) Overweight Rating Reaffirmed at StephensJuly 10, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Issues Quarterly Earnings ResultsJuly 10, 2025 | marketbeat.comNurix Therapeutics, Inc.: Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate UpdateJuly 10, 2025 | finanznachrichten.deNurix Therapeutics Reports Increased Revenue Amid Net LossJuly 9, 2025 | tipranks.comNurix Therapeutics Climbs After 2Q Revenue TriplesJuly 9, 2025 | marketwatch.comNurix Therapeutics beats quarterly expectations on strong collaboration revenueJuly 9, 2025 | in.investing.comNurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate UpdateJuly 9, 2025 | globenewswire.comNurix Therapeutics (NASDAQ:NRIX) Trading 7.8% Higher - Still a Buy?July 9, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $30.18 Average Price Target from AnalystsJuly 8, 2025 | americanbankingnews.comEuropean Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström MacroglobulinemiaJuly 7, 2025 | globenewswire.comWall Street Analysts Predict a 143.41% Upside in Nurix Therapeutics (NRIX): Here's What You Should Know - NasdaqJuly 5, 2025 | nasdaq.comNurix Therapeutics, Inc. (NRIX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - NasdaqJuly 5, 2025 | nasdaq.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Recommendation of "Moderate Buy" from AnalystsJuly 5, 2025 | marketbeat.comHC Wainwright Brokers Increase Earnings Estimates for NRIXJuly 5, 2025 | americanbankingnews.comSumitomo Mitsui Trust Group Inc. Sells 33,252 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)July 4, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for NRIX FY2026 Earnings?July 4, 2025 | americanbankingnews.comHC Wainwright Issues Optimistic Estimate for NRIX EarningsJuly 3, 2025 | marketbeat.comNurix Therapeutics (NRIX) Projected to Post Earnings on ThursdayJuly 3, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Trading 8% Higher - What's Next?July 2, 2025 | marketbeat.comFY2026 Earnings Forecast for NRIX Issued By HC WainwrightJuly 2, 2025 | marketbeat.comNurix Therapeutics, Inc. (NRIX) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comNRIX Nurix Therapeutics, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comNurix Therapeutics (NASDAQ:NRIX) Stock Price Down 4.5% - Should You Sell?June 25, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Upgraded to Hold at Wall Street ZenJune 21, 2025 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Align Tech (ALGN), Nurix Therapeutics (NRIX) and Thermo Fisher (TMO)June 18, 2025 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and Telix Pharmaceuticals (OtherTLPPF)June 14, 2025 | theglobeandmail.comNurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 13, 2025 | globenewswire.comNurix drops after new early-stage trial data for lead assetJune 13, 2025 | msn.comNurix Therapeutics (NASDAQ:NRIX) Shares Down 5.9% - What's Next?June 12, 2025 | marketbeat.comNurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Waldenström Macroglobulinemia (WM)June 12, 2025 | globenewswire.comTruist Financial Sticks to Its Buy Rating for Nurix Therapeutics (NRIX)June 11, 2025 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Dexcom (DXCM) and Immunovant (IMVT)June 10, 2025 | theglobeandmail.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Rating of "Moderate Buy" from BrokeragesJune 10, 2025 | marketbeat.comNurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)June 6, 2025 | globenewswire.comNurix Therapeutics (NASDAQ:NRIX) Shares Gap Up - Time to Buy?June 3, 2025 | marketbeat.comSanofi Exercises License Extension Option to Nurix’s STAT6 ProgramJune 3, 2025 | finance.yahoo.comSanofi Exercises License Extension Option to Nurix's STAT6 ProgramJune 2, 2025 | globenewswire.comTwo Sigma Investments LP Purchases 84,375 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)June 1, 2025 | marketbeat.comNuveen Asset Management LLC Trims Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)May 31, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Trading 3.9% Higher - Should You Buy?May 30, 2025 | marketbeat.com Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address NRIX Media Mentions By Week NRIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRIX News Sentiment▼0.311.01▲Average Medical News Sentiment NRIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRIX Articles This Week▼266▲NRIX Articles Average Week Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RARE News AAPG News MRUS News ACLX News SWTX News RNA News ACAD News SRRK News VKTX News PTGX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRIX) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRIX Stock Alerts